AIM The “2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial
Fibrillation” provides recommendations to guide clinicians in the treatment of patients with …

• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

The global prevalence of atrial fibrillation (AF) has increased substantially over the past
three decades and is currently approximately 60 million cases. Incident AF and its clinical …

Catheter ablation for atrial fibrillation (AF) has emerged as an important rhythm-control
strategy and is by far the most common cardiac ablation procedure performed worldwide …

Background There are limited data on the effect of exercise interventions on atrial fibrillation
(AF) recurrence and symptoms. Objectives The aim of this study was to determine the …

Aims To develop quality indicators (QIs) that may be used to evaluate the quality of care and
outcomes for adults with atrial fibrillation (AF). Methods and results We followed the ESC …

Abstract Cardiovascular (CV) disease (CVD) remains the leading cause of major morbidity
and CVD-and all-cause mortality in most of the world. It is now clear that regular physical …

Objective A systematic review, meta-analysis and meta-regression were performed on
selected studies to investigate the incidence of atrial fibrillation (AF) among athletes …

Aims Lifestyle risk factors are a modifiable target in atrial fibrillation (AF) management. The
relative contribution of individual lifestyle risk factors to AF development has not been …

Atrial enlargement in response to pathological stimuli (eg, hypertension, mitral valve
disease) and physiological stimuli (exercise, pregnancy) can be comparable in magnitude …